Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for Sunshine Biopharma (SBFM) over the last 1 years, with Sep 2025 value amounting to -0.24%.

  • Sunshine Biopharma's Return on Invested Capital was N/A to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year change of. This contributed to the annual value of -0.25% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Return on Invested Capital is -0.24%, which was up 8.66% from -0.26% recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Return on Invested Capital registered a high of -0.19% during Q2 2024, and its lowest value of -0.26% during Q2 2025.
  • Moreover, its 2-year median value for Return on Invested Capital was -0.23% (2025), whereas its average is -0.23%.
  • Data for Sunshine Biopharma's Return on Invested Capital shows a maximum YoY fell of 7bps (in 2025) over the last 5 years.
  • Sunshine Biopharma's Return on Invested Capital (Quarterly) stood at -0.23% in 2024, then fell by 7bps to -0.24% in 2025.
  • Its last three reported values are -0.24% in Q3 2025, -0.26% for Q2 2025, and -0.23% during Q1 2025.